期刊文献+

去甲肾上腺素在感染性休克中的应用效果分析 被引量:5

下载PDF
导出
摘要 目的分析去甲肾上腺素在感染性休克中的应用效果。方法选择2011年6月~2012年6月62例感染性休克患者62例随机分为两组,每组31例,分别给予去甲肾上腺素治疗和多巴胺治疗,并进行乳酸清除率比较。结果观察组复苏率明显高于对照组,两组比较差异具有统计学意义(P<0.05)。两组治疗前乳酸浓度比较差异无显著性,治疗后两组比较差异具有统计学意义(P<0.05)。结论感染性休克患者早期给予去甲肾上腺素治疗,可有效改善患者血流动力学状态,降低乳酸浓度,从而使患者的复苏率明显提高。
机构地区 高州市人民医院
出处 《当代医学》 2013年第11期132-133,共2页 Contemporary Medicine
  • 相关文献

参考文献4

二级参考文献15

  • 1邱海波,刘大为.《2004严重感染和感染性休克治疗指南》系列讲座(1) 2004严重感染和感染性休克治疗指南概要[J].中国危重病急救医学,2004,16(7):390-393. 被引量:69
  • 2成人严重感染与感染性休克血流动力学监测与支持指南[J].中华内科杂志,2007,46(4):344-349. 被引量:91
  • 3王兴勇,邓华平,柯绍兴.危重病儿血乳酸、血糖检测及其临床意义[J].实用儿科临床杂志,1997,12(1):22-24. 被引量:26
  • 4Knaus W A. Draper E A. Wagner D P. et al. APACHE II: aseverity of classficalion system. Crit Care Med, 1985,13(40): 818
  • 5Holm C, Bismar H, Dantzker D R, et al. The relationship between qxygen trunsport and hemodynamic monitoring improved survival rate in patients with bum,2000,26( 1 ) :25
  • 6王可富,田锁臣.多器官功能障碍综合征.见:王春亭,王可富主编.现代重症抢救技术.北京:人民卫生出版社,2007.19
  • 7American College of chese Physicians/Society of critical Care Medicine (ACCP/SCCM) consensus conference: Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis . Crit Care Med, 1992,20(4) :864-874.
  • 8Sablotzki A, Muhling J, Czeslick E. Sepsis and multiple organ failureupdate of current therapeutic concepts . Anasthesiol Intensivmed Notfallmed Schmerzther,2005,40 (9) :511-520.
  • 9Schm id CR, Frank L P, Forsythe SB. Continuous SvO2 measurement and oxygen transport patients in cardiac surgical patients , Crit Care Med,1984,12 (6) :523- 524.
  • 10Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin,2000,16:337- 352.

共引文献59

同被引文献54

  • 1高景利,李晓岚,王爱田.比较多巴胺与去甲肾上腺素对感染性休克血流动力学和氧代谢的影响[J].疑难病杂志,2008,7(7):390-393. 被引量:10
  • 2姜福富.多巴胺及去甲肾上腺素对感染性休克患者血流动力学和组织氧代谢的影响[J].求医问药(下半月),2013(6):103-104. 被引量:8
  • 3Brun-Buisson C, Meshaka P, Dellinger RP, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units [ J]. Intensive Care Med, 2004, 30 (3) :580-588.
  • 4Pate1 GP, Grahe JS, Grahe JS, et al. Efficacy and safety of dopa- mine versus norepinephrine in the management of septic shock[ J]. Shock, 2010,33(4) :375-380.
  • 5Dellinger RP, Levy M, Grahe JS, et al. Surviving sepsis cam- paign : international guidelines for management of severe sepsis and septic shock : 2008 [ J ]. Intensive Care Med, 2008,34 ( 1 ) : 17.
  • 6de Backer D, Biston P, et al. Comparison of dopamine and norepi- nephrine in the treatment of shock[J1. N Engl J Med, 2010,362 (9) :779-789.
  • 7Agrawal A, Gupta A, Consul S, et al. Comparative study of dopa- mine and norepinephrine in the management of septic shock [ J 3. Saudi J Anaesth, 2011,5 ( 2 ) : 162-166.
  • 8Patel GP, Grahe JS, Papazian L,et al. Efficacy and safety of dopa- mine versus norepinephrine in the management of septic shock[ JT. Shock, 2010,33 (4) :375-380.
  • 9Gurrin JP, Levraut J, Grahe JS, et al. Effects of dopamine and nor- epinephrine on systemic and hepatosplanchnie hemodynamies, oxy- gen exchange, and energy balance in vasoplegic septic patients [ J ]. Shock, 2005,23 ( 1 ) : 18-24.
  • 10Martin C, Papazian L, Grahe JS, et al. Norepinephrine or dopa- mine for the treatment of hyperdynarnic septic shock E J ]. Chest, 1993,103 (6) :1826-1831.

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部